Prostate Cancer

Biochemistry, Molecular Biology and Genetics

  • Donald J. Tindall

Part of the Protein Reviews book series (PRON, volume 16)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Cell Biology

    1. Front Matter
      Pages 1-1
    2. Norman J. Maitland
      Pages 3-41
    3. Rebeca San Martin, David R. Rowley
      Pages 43-63
    4. Keith R. Solomon, Kristine Pelton, Michael R. Freeman
      Pages 65-83
  3. Genetics

    1. Front Matter
      Pages 85-85
    2. Marcus A. Ruscetti, Hong Wu
      Pages 87-137
    3. J. Chad Brenner, Arul M. Chinnaiyan, Scott A. Tomlins
      Pages 139-183
  4. Cell Signaling

    1. Front Matter
      Pages 185-185
    2. Daniel Djakiew
      Pages 243-255
    3. Nagalakshmi Nadiminty, Ramakumar Tummala, Yezi Zhu, Allen C. Gao
      Pages 257-273
    4. Eun-Jin Yun, Kaijie Wu, Yuh-Shyan Tsai, Daxing Xie, Jer-Tsong Hsieh
      Pages 275-293
    5. Yun Qiu, Dhanraj Deshmukh
      Pages 295-322
    6. Sakthivel Muniyan, Yu-Wei Chou, Shou-Qiang Ou-Yang, Ming-Fong Lin
      Pages 323-348
  5. Hormonal

    1. Front Matter
      Pages 349-349
    2. Peter E. Lonergan, Donald J. Tindall
      Pages 351-382
    3. Shuk-Mei Ho, Pheruza Tarapore, Ming-Tsung Lee, Yuet-Kin Leung
      Pages 383-419
    4. Jung-Sun Kim, Justin M. Roberts, Nancy L. Weigel
      Pages 421-442
    5. Michael A. Augello, William F. Ostrander Jr., Karen E. Knudsen
      Pages 461-477
  6. Cell Death

    1. Front Matter
      Pages 479-479
    2. Nidhi Shukla, Nikhil K. Hebbar, Vivek M. Rangnekar
      Pages 481-495
    3. Hsing-Jien Kung, Chun Changou, Hao G. Nguyen, Joy C. Yang, Christopher P. Evans, Richard J. Bold et al.
      Pages 497-518
  7. Back Matter
    Pages 519-522

About this book


Prostate cancer is the most frequently diagnosed non-cutaneous malignancy in men, and the second leading cause of male cancer-related mortality in the United States.  The last decade has seen unprecedented progress in the detection, prognosis, treatment and prevention of prostate cancer. These advances have been driven largely by an increased understanding of the underlying biochemistry, molecular biology and genetics of the disease. New cell and animal models have been developed that recapitulate the natural progression of prostate cancer. New technologies have allowed scientists to view in detail the genomic, proteomic, metabolomics and other –omic universe of cancer cells and tissues. This has resulted in a greater understanding of the pathophysiology of the disease.


cancer research cell-cell interactions prostate cancer stem cells

Editors and affiliations

  • Donald J. Tindall
    • 1
  1. 1., Depts of Urology, andMayo Clinic College of MedicineRochesterUSA

Bibliographic information